Abstract
This work describes the de-novo design of peptides that inhibit a broad range of plant pathogens. Four structurally different groups of peptides were developed that differ in size and position of their charged and hydrophobic clusters and were assayed for their ability to inhibit bacterial growth and fungal spore germination. Several peptides are highly active at concentrations between 0,1 and 1 µg/ml against plant pathogenic bacteria, such as Pseudomonas syringae, Pectobacterium carotovorum, and Xanthomonas vesicatoria. Importantly, no hemolytic activity could be detected for these peptides at concentrations up to 200 µg/ml. Moreover, the peptides are also active after spraying on the plant surface demonstrating a possible way of application. In sum, our designed peptides represent new antimicrobial agents and with the increasing demand for antimicrobial compounds for production of "healthy" food, these peptides might serve as templates for novel antibacterial and antifungal agents.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Anti-Infective Agents / chemistry*
-
Anti-Infective Agents / pharmacology*
-
Antimicrobial Cationic Peptides / chemistry*
-
Antimicrobial Cationic Peptides / pharmacology*
-
Arabidopsis / drug effects
-
Arabidopsis / microbiology
-
Drug Design
-
Hemolysis / drug effects
-
Hydrophobic and Hydrophilic Interactions
-
Membrane Potentials / drug effects
-
Microbial Sensitivity Tests
-
Models, Molecular
-
Molecular Sequence Data
-
Phenotype
-
Plant Diseases / microbiology
-
Plant Diseases / prevention & control*
-
Plants / drug effects*
-
Plants / microbiology
-
Protein Conformation
Substances
-
Anti-Infective Agents
-
Antimicrobial Cationic Peptides
Grants and funding
This work was supported by Deutsche Forschungsgemeinschaft (SPP 1110 Innate Immunity) and by Bayerisches Staatsministerium für Umwelt, Gesundheit und Verbraucherschutz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.